Autoimmune Encephalitis (AE)

Explore clinical trials studying Autoimmune Encephalitis (AE). Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Autoimmune Encephalitis (AE) trial results

Recruiting

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

NCT07337785

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Autoimmune Encephalitis (AE), +26 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

NCT07526493

Conditions: Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD), Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +37 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis?

NCT07488117

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Autoimmune Encephalitis (AE), +2 more
Locations: University Hospital Toulouse, France

View Trial Details

Not Yet Recruiting

A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults

NCT07583641

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Autoimmune Encephalitis (AE), +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Plasma Exchange in Pediatric Autoimmune Encephalitis

NCT07707739

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Autoimmune Encephalitis (AE), +2 more
Locations: Menoufia university hospital, Pediatric intensive care unit Shibīn al Kawm, Menoufia Governorate, Egypt

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis

NCT07686042

Conditions: Autoimmune Cerebellitis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +3 more
Locations: Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Active, Not Recruiting

OPM- MEG in Non-immune And iMmune-medIated Neurological Disease

NCT07689682

Conditions: Acute Disseminated Encephalomyelitis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more
Locations: Aston University Birmingham, United Kingdom

View Trial Details

Autoimmune Encephalitis (AE)

Autoimmune Encephalitis (AE) trial results

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Is [18F]-DPA-714 PET a Good Marker of Neuroinflammation in Autoimmune Encephalitis?

A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults

Plasma Exchange in Pediatric Autoimmune Encephalitis

Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis

OPM- MEG in Non-immune And iMmune-medIated Neurological Disease

Related conditions